Impact of HLA-DR and combined HLA-B and HLA-DR matching on early graft outcome under cyclosporine therapy.
Vanrenterghem
Y
Y
Department of Renal Transplantation, University of Leuven, Belgium.
Roels
L
L
Waer
M
M
Gruwez
J
J
Dendievel
J
J
Michielsen
P
P
D003524:Cyclosporins / Q000627:therapeutic use*; D006084:Graft Rejection / Q000276:immunology; D006085:Graft Survival / Q000276:immunology; D015235:HLA-B Antigens / Q000276:immunology*; D006684:HLA-DR Antigens / Q000276:immunology*; D006650:Histocompatibility Testing; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology*; D014184:Transplantation, Homologous
D003524:Cyclosporins; D015235:HLA-B Antigens; D006684:HLA-DR Antigens